Daniel Billen serves as Executive at Aurinia Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Daniel Billen has executed 4 insider transactions totaling $82.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 21, 2024 involved selling 5,252 shares valued at $30.1K.
Daniel Billen currently holds 28,141 shares of Aurinia Pharmaceuticals Inc. (AUPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Billen has been a net seller of AUPH stock. They have purchased $0 and sold $82.5K worth of shares.
Daniel Billen's most recent insider trade was on May 21, 2024, when they sold 5,252 shares at $5.74 per share.
Get notified when new Form 4 filings are submitted
| $11.26 |
| Discretionary |
| May 19, 2023 | AUPH | $0 | Award | 9,310 | $N/A | Discretionary |
| May 18, 2023 | AUPH | $0 | Option Exercise | 8,733 | $N/A | Discretionary |